Syngene trims FY26 revenue guidance by up to 5% as inventory correction for veterinary drug Librela hits profits, even as ...

Syngene International is launching a strategic collaboration with Johns Hopkins University to advance early-stage drug ...

Syngene International’s profits declined 89 per cent year on year to Rs 15 crore on a consolidated basis for the third quarter of the financial year 2026 (Q3 FY26). Revenue from operations also fell 3 ...

Syngene International has partnered with Johns Hopkins University to accelerate early-stage drug discovery. Using Syngene SynVent, a comprehensive drug development platform, they aim to speed up ...

MUMBAI (Reuters) - Biotechnology firm Biocon Ltd(BION.NS) could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two ...

Shares of Syngene International declined by 2.10% to Rs 445.55 at 9:31 am on Thursday. The stock is a constituent of the Nifty Midcap 150 index. The consolidated financial performance of Syngene ...

Syngene-international: Get the latest Syngene-international news, photos, videos, and podcasts. Explore more for Syngene-international breaking news, opinions, special reports, and more on mint.

Continued inventory correction for Syngene’s largest commercial biologics product drags earnings for a second straight quarter.

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), reports that that its newly upgraded biologics facility (Unit 3) in Bangalore, India, will be ...

BENGALURU, India, Jan. 20, 2026 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its ...

BENGALURU (Reuters) -India's Syngene International Ltd aims to supply half-a-million vials of COVID-19 drug remdesivir through its local distribution partners next month, its top executive said, as ...